Hemogram-based decision tree models for discriminating COVID-19 from RSV in infants

J Clin Lab Anal. 2023 Mar;37(6):e24862. doi: 10.1002/jcla.24862. Epub 2023 Mar 27.

Abstract

Objective: Decision trees are efficient and reliable decision-making algorithms, and medicine has reached its peak of interest in these methods during the current pandemic. Herein, we reported several decision tree algorithms for a rapid discrimination between coronavirus disease (COVID-19) and respiratory syncytial virus (RSV) infection in infants.

Methods: A cross-sectional study was conducted on 77 infants: 33 infants with novel betacoronavirus (SARS-CoV-2) infection and 44 infants with RSV infection. In total, 23 hemogram-based instances were used to construct the decision tree models via 10-fold cross-validation method.

Results: The Random forest model showed the highest accuracy (81.8%), while in terms of sensitivity (72.7%), specificity (88.6%), positive predictive value (82.8%), and negative predictive value (81.3%), the optimized forest model was the most superior one.

Conclusion: Random forest and optimized forest models might have significant clinical applications, helping to speed up decision-making when SARS-CoV-2 and RSV are suspected, prior to molecular genome sequencing and/or antigen testing.

Keywords: COVID-19; RSV; children; decision tree; machine learning.

MeSH terms

  • COVID-19* / diagnosis
  • Cross-Sectional Studies
  • Decision Trees
  • Humans
  • Infant
  • Predictive Value of Tests
  • Respiratory Syncytial Virus Infections* / diagnosis
  • SARS-CoV-2